These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22267618)

  • 1. Update on the clinical use of buprenorphine: in opioid-related disorders.
    Ducharme S; Fraser R; Gill K
    Can Fam Physician; 2012 Jan; 58(1):37-41. PubMed ID: 22267618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction.
    Robinson SE
    CNS Drug Rev; 2002; 8(4):377-90. PubMed ID: 12481193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid agonist treatment for pharmaceutical opioid dependent people.
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
    Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine for the treatment of opioid dependence.
    Boothby LA; Doering PL
    Am J Health Syst Pharm; 2007 Feb; 64(3):266-72. PubMed ID: 17244875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.
    Bonhomme J; Shim RS; Gooden R; Tyus D; Rust G
    J Natl Med Assoc; 2012; 104(7-8):342-50. PubMed ID: 23092049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification.
    Helm S; Trescot AM; Colson J; Sehgal N; Silverman S
    Pain Physician; 2008; 11(2):225-35. PubMed ID: 18354714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava A; Kahan M; Nader M
    Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials.
    Klimas J; Hamilton MA; Gorfinkel L; Adam A; Cullen W; Wood E
    Syst Rev; 2021 Aug; 10(1):216. PubMed ID: 34362464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
    Kleber HD
    Dialogues Clin Neurosci; 2007; 9(4):455-70. PubMed ID: 18286804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.
    Jutras-Aswad D; Le Foll B; Ahamad K; Lim R; Bruneau J; Fischer B; Rehm J; Wild TC; Wood E; Brissette S; Gagnon L; Fikowski J; Ledjiar O; Masse B; Socias ME;
    Am J Psychiatry; 2022 Oct; 179(10):726-739. PubMed ID: 35702828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine for cocaine and opiate dependence.
    Kosten TR; Rosen MI; Schottenfeld R; Ziedonis D
    Psychopharmacol Bull; 1992; 28(1):15-9. PubMed ID: 1609037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse.
    Husbands SM; Lewis JW
    Mini Rev Med Chem; 2003 Mar; 3(2):137-44. PubMed ID: 12570846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002025. PubMed ID: 15495026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.
    Neumann AM; Blondell RD; Jaanimägi U; Giambrone AK; Homish GG; Lozano JR; Kowalik U; Azadfard M
    J Addict Dis; 2013; 32(1):68-78. PubMed ID: 23480249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine: new treatment of opioid addiction in primary care.
    Kahan M; Srivastava A; Ordean A; Cirone S
    Can Fam Physician; 2011 Mar; 57(3):281-9. PubMed ID: 21402963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
    Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
    J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
    [No Abstract]   [Full Text] [Related]  

  • 19. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing opioid addiction with buprenorphine.
    Donaher PA; Welsh C
    Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.